Aviva Research and Development Expenses 2012-2025 | AVVIY

Aviva annual/quarterly research and development expenses history and growth rate from 2012 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Aviva research and development expenses for the quarter ending December 31, 2025 were $0M, a 0% increase year-over-year.
  • Aviva research and development expenses for the twelve months ending December 31, 2025 were $0M, a 0% increase year-over-year.
  • Aviva annual research and development expenses for 2025 were $0B, a 0% decline from 2024.
  • Aviva annual research and development expenses for 2024 were $0B, a 0% decline from 2023.
  • Aviva annual research and development expenses for 2023 were $0B, a 0% decline from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Aviva Annual Research and Development Expenses
(Millions of US $)
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Aviva Quarterly Research and Development Expenses
(Millions of US $)
2025-12-31
2025-06-30
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2015-12-31
2015-06-30
2014-12-31
2014-06-30
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
2011-06-30
Sector Industry Market Cap Revenue
Finance Life Insurance Providers $25.698B $33.539B
Aviva has established a competitive position in North America. In the US, the world's largest savings market, Aviva is the leading provider of indexed annuity and indexed life insurance products. Its principal activity is the provision of financial products and services, focused on the following lines of business: long-term insurance and savings business, fund management and general insurance and health. The company's business is managed on a geographic basis through a regional management structure based on four regions, U.K., Europe, North America and Asia Pacific. The four regions function as five operating segments as, due to the size of the U.K. region, it is split into two operating segments, U.K. Life and U.K. General Insurance, which undertake long term insurance and savings business and general insurance respectively.
Stock Name Country Market Cap PE Ratio
AIA (AAGIY) Hong Kong, SAR China $119.768B 0.00
Manulife Financial Corp (MFC) Canada $61.070B 12.09
Sun Life Financial (SLF) Canada $36.153B 12.27
NN Group (NNGRY) Netherlands $21.903B 0.00
Reinsurance Group Of America (RGA) United States $13.433B 8.37
Primerica (PRI) United States $8.270B 11.39
Jackson Financial (JXN) United States $7.183B 4.47
Lincoln National (LNC) United States $6.501B 4.17
Voya Financial (VOYA) United States $6.488B 7.82
Brighthouse Financial (BHF) United States $3.473B 3.78
Genworth Financial (GNW) United States $3.389B 25.74
F&G Annuities & Life (FG) United States $3.259B 6.64
Baldwin Insurance (BWIN) United States $3.056B 20.18
Abacus Life (ABL) United States $0.828B 11.15
Kansas City Life Insurance (KCLI) United States $0.306B 22.70
Citizens (CIA) United States $0.270B 16.24
Security National Financial (SNFCA) United States $0.248B 7.57
UTG (UTGN) United States $0.195B 11.44
GoHealth (GOCO) United States $0.030B 0.00